Skip to main content
. 2011 Oct;164(3):992–1007. doi: 10.1111/j.1476-5381.2011.01390.x

Figure 12.

Figure 12

Simulations of an 80 mg clinical dose of the CRF1 antagonist, R121919 (see text for details). Solid line represents a simulation using the in vitro derived parameters, whereas the dotted and dashed lines represent a fivefold increase and decrease of kon respectively.